Jaume Pons founded ALX Oncology Holdings, Inc. and ALX Oncology Ltd. Presently, he occupies the position of President, Chief Executive Officer & Director at ALX Oncology Holdings, Inc. and President, Chief Executive Officer & Director at ALX Oncology Ltd. and President & Chief Executive Officer at ALX Oncology, Inc. (both are subsidiaries of ALX Oncology Holdings, Inc.) and Venture Partner at venBio Partners LLC. Jaume Pons is also on the board of Tallac Therapeutics, Inc. (former Chief Executive Officer), Alexo Therapeutics International and Sirpant Therapeutics.

In the past he was Chief Scientific Officer of Pfizer Inc. and Chief Scientific Officer at Rinat Neuroscience Corp. (a subsidiary of Pfizer Inc.).

He received an undergraduate degree, a doctorate and a graduate degree from Universitat Autònoma de Barcelona.